<DOC>
	<DOCNO>NCT00611741</DOCNO>
	<brief_summary>This study design test hypothesis plasma osmolality link cortical glutamate concentration brain . It also investigate whether glutamate response schizophrenia enhance compare healthy control .</brief_summary>
	<brief_title>The Effect Plasma Osmolality Brain Glutamate</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<criteria>Inclusion criterion healthy control 1 . Ages 2145 year ethnic background . 2 . Male female . 3 . Written informed consent . 4 . Female subject study follicular phase menstrual cycle . * Exclusion criterion healthy control 1 . DSMIV diagnosis psychotic , anxiety , mood disorder . 2 . A history significant medical/neurological disease . Unstable medical condition base EKG , vital sign , physical examination laboratory workup ( CBC differential , SMA7 , LFTs , TFTs , UA , Utox , Urine pregnancy test , folic acid , B12 level ) . 3 . History allergy drug sulfa , multiple adverse drug reaction know allergy furosemide . 4 . Any medication opinion PI could interfere either safety study and/or outcome measure , counter cough suppressant antihistamine . 5 . History major psychiatric disorder firstdegree relative . 6 . Current substance abuse/dependency determine plasma urine toxicology . 7 . Current treatment medication psychotropic effect . 8 . Current pregnancy , unsatisfactory birth control method report female . 9 . Education &lt; 12th grade . 10 . NonEnglish speaking . Inclusion criteria patient schizophrenia 1 . Ages 2145 year ethnic background . 2 . Male female . 3 . Written informed consent . 4 . DSMIV diagnosis schizophrenia schizoaffective disorder . 5 . For treated patient : The patient stable dose medication ( antipsychotic , antidepressant ) past month require change medication dose adjustment study entry . 6 . For untreated patient : Has refuse treat medication , maintain regular clinic appointment clinician , pose imminent danger others . 7 . Female subject study follicular phase menstrual cycle* . Exclusion criteria patient schizophrenia 1 . A history significant medical/neurological disease . Unstable medical condition base EKG , vital sign , physical examination laboratory workup ( CBC differential , SMA7 , LFTs , TFTs , UA , Utox , Urine pregnancy test , folic acid , B12 level ) . 2 . Orthostatic systolic blood pressure change &gt; 20 mmHg orthostatic pulse change &gt; 20 bpm . 3 . History polydipsia/hyponatremia** . 4 . History allergy drug sulfa , multiple adverse drug reaction know allergy furosemide . 5 . Any medication opinion PI could interfere either safety study and/or outcome measure , counter cough suppressant antihistamine . 6 . Current use lithium ( lithium directly interfere electrolyte balance ) . 7 . Currently clozapine clozapine may interfere brain water regulation ( Leadbetter Shutty , 1994 ) . 8 . Current substance abuse/dependency determine plasma urine toxicology . 9 . Current treatment benzodiazepine mood stabilizer ( medication alter glutamate transmission ) . 10 . Current pregnancy , unsatisfactory birth control method report female . 11 . IQ &lt; 70 determined Wechsler Abbreviated Scale Intelligence . 12 . NonEnglish speaking</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>MRS , glutamate , osmolality</keyword>
</DOC>